Lipid Metabolism Practice Questions

Q: Which of the following is a true difference between gangliosides and cerebrosides?

Charge difference. ***Charge difference*** - **Gangliosides** contain **sialic acid (N-acetylneuraminic acid)** residues, which are negatively charged, making gangliosides **anionic**. - **Cerebrosides** are **neutral glycosphingolipids** as they lack charged sugar residues. *Specific carbohydrate composition* - While both have carbohydrate components, referring to "specific carbohydrate composition" as the *true difference* is too broad. Both have characteristic sugar groups, but the **presence of sialic acid** in gangliosides is the key differentiator in charge. - Cerebrosides typically contain a single sugar (either glucose or galactose), whereas gangliosides have a more complex oligosaccharide chain including sialic acid. *Presence of glucose* - Both cerebrosides (specifically **glucocerebrosides**) and gangliosides can contain **glucose** in their carbohydrate moieties. - This is not a distinguishing feature; the *type* and *arrangement* of sugars, particularly the presence of sialic acid, are more specific. *Location in the nervous system* - Both gangliosides and cerebrosides are abundant in the **nervous system**, particularly in cell membranes. - Their presence in the nervous system is a similarity, not a differentiating factor.

Q: Enzyme deficient in Type I Hyperlipidemia?

Lipoprotein lipase. ***Lipoprotein lipase*** - **Type I hyperlipidemia**, also known as **familial hyperchylomicronemia**, is characterized by a deficiency in **lipoprotein lipase (LPL)**. - LPL is crucial for hydrolyzing triglycerides in **chylomicrons** and **VLDLs** into fatty acids and glycerol, allowing their uptake by tissues. *HMG CoA reductase* - This enzyme is involved in the **rate-limiting step of cholesterol synthesis** in the liver. - While it plays a role in lipid metabolism, its deficiency is not characteristic of **Type I hyperlipidemia**. *Peroxidase* - **Peroxidase** is an enzyme involved in various oxidative reactions, including the breakdown of **hydrogen peroxide**. - It is not directly involved in the metabolism of **chylomicrons** or **triglycerides**, and its deficiency is unrelated to hyperlipidemia. *Cholesterol acyl transferase* - This enzyme, often referring to **lecithin-cholesterol acyltransferase (LCAT)** or **acyl-CoA:cholesterol acyltransferase (ACAT)**, is involved in **cholesterol esterification**. - While important for cholesterol transport and storage, its deficiency is not the primary cause of **Type I hyperlipidemia**, which is marked by severe **chylomicronemia**.

Q: Which of the following is monoenoic acid ?

Oleic acid. ***Oleic acid*** - **Oleic acid** is a **monounsaturated fatty acid** (MUFA), meaning it has **one double bond** in its hydrocarbon chain. - Its presence in many natural fats and oils makes it a significant component of the human diet. *Arachidonic acid* - **Arachidonic acid** is a **polyunsaturated fatty acid** (PUFA) containing **four double bonds**. - It is a precursor for **eicosanoids**, including prostaglandins and leukotrienes, involved in inflammation and other physiological processes. *Linoleic acid* - **Linoleic acid** is an **essential omega-6 polyunsaturated fatty acid** with **two double bonds**. - It is crucial for human health and serves as a precursor for other fatty acids like arachidonic acid. *Linolenic acid* - **Linolenic acid** refers to two essential fatty acids: **alpha-linolenic acid (ALA)**, an omega-3 fatty acid with **three double bonds**, and **gamma-linolenic acid (GLA)**, an omega-6 fatty acid also with three double bonds. - Both are **polyunsaturated fatty acids** with multiple double bonds.

Q: Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Acetyl CoA. ***Acetyl CoA*** - **Acetyl CoA** is the ultimate source of all acetyl groups used in fatty acid synthesis - It serves as the substrate for **acetyl CoA carboxylase**, which converts it to **malonyl CoA** - After transport from mitochondria via **citrate**, acetyl CoA is the precursor for all two-carbon units incorporated into fatty acids - One molecule of acetyl CoA also serves as the primer for fatty acid synthesis *Malonyl CoA* - **Malonyl CoA** is the direct two-carbon donor to the growing fatty acid chain - However, it is derived from **acetyl CoA** through carboxylation by **acetyl CoA carboxylase** - It is an intermediate, not the ultimate source of acetyl groups *Palmitate* - **Palmitate** is a 16-carbon saturated fatty acid that is the end product of de novo fatty acid synthesis - It is the product of fatty acid synthesis, not a donor of acetyl groups *Citrate* - **Citrate** transports acetyl groups from the **mitochondria** to the **cytosol** where fatty acid synthesis occurs - In the cytosol, **ATP citrate lyase** cleaves citrate back into **acetyl CoA** and oxaloacetate - Citrate is a transport vehicle, not the ultimate source of acetyl groups

Q: Apo-E deficiency is seen in which of the following conditions?

Type III hyperlipoproteinemia. ***Type III hyperlipoproteinemia*** - This condition, also known as **familial dysbetalipoproteinemia** or **broad beta disease**, is characterized by a deficiency or abnormal function of **apolipoprotein E (apoE)**. - The deficiency in functional apoE impairs the clearance of **chylomicron remnants** and **intermediate-density lipoproteins (IDLs)** from the blood. *Type II hyperlipoproteinemia* - This condition primarily involves elevated **LDL cholesterol** and is often due to defects in the **LDL receptor** or mutations in **apoB-100**, not apoE deficiency. - It does not directly involve the impaired clearance of chylomicron remnants or IDLs. *Type I hyperlipoproteinemia* - Also known as **familial chylomicronemia syndrome**, this condition is characterized by severe elevation of **chylomicrons** and **triglycerides**. - It is caused by a deficiency of **lipoprotein lipase (LPL)** or its cofactor **apoC-II**, not apoE. *Type IV hyperlipoproteinemia* - This condition, also known as **familial hypertriglyceridemia**, is characterized by abnormally high levels of **very-low-density lipoproteins (VLDL)** and **triglycerides**. - It is typically caused by increased VLDL production or impaired VLDL clearance, but not directly due to an apoE deficiency.

Q: At which positions does pancreatic lipase hydrolyze the ester linkages of triacylglycerides?

1 and 3. **Correct: 1 and 3** - Pancreatic lipase specifically targets the **ester bonds at the sn-1 and sn-3 positions** (primary alcohol positions) on the glycerol backbone of triacylglycerides. - This positional specificity results in the formation of **2-monoacylglycerol (2-MAG)** and **two free fatty acids**. - This is the characteristic action of pancreatic triacylglycerol lipase during fat digestion in the intestinal lumen. *Incorrect: 1 and 2* - Hydrolysis at positions 1 and 2 would produce a 3-monoacylglycerol and free fatty acids, which is not the physiological product of pancreatic lipase. - The enzyme's positional specificity favors the outer sn-1 and sn-3 positions, not the middle sn-2 position. *Incorrect: 2 and 3* - Hydrolysis at positions 2 and 3 would yield a 1-monoacylglycerol and free fatty acids, which does not reflect pancreatic lipase activity. - The enzyme specifically spares the sn-2 position due to its structural specificity. *Incorrect: Only 3* - If only position 3 were hydrolyzed, the product would be a 1,2-diacylglycerol and one free fatty acid. - This represents incomplete hydrolysis; pancreatic lipase typically hydrolyzes **both outer positions (sn-1 and sn-3)** due to its regiospecificity.

Q: Chylomicron remnants are associated with ?

Apo-E. ***Apo-E*** - **Apolipoprotein E (Apo-E)** is a crucial apolipoprotein on the surface of chylomicron remnants, acting as a **ligand for the LDL receptor-related protein 1 (LRP1)** in the liver. - This binding facilitates the **hepatic uptake and clearance** of chylomicron remnants from circulation. *Apo-A* - **Apo-AI** is the primary apolipoprotein of **HDL** and plays a key role in reverse cholesterol transport by activating **lecithin-cholesterol acyltransferase (LCAT)**. - While chylomicrons *acquire* some Apo-AI from HDL, it is not the primary apolipoprotein defining their remnants' hepatic clearance. *Apo-C* - **Apo-CII** is a vital activator of **lipoprotein lipase (LPL)**, which metabolizes triglycerides in chylomicrons and VLDL. - **Apo-CIII** inhibits LPL and hinders receptor-mediated uptake, but **Apo-E** is the key for remnant recognition and uptake, not Apo-C in general. *Apo-B100* - **Apo-B100** is the main structural apolipoprotein of **LDL** and **VLDL**, serving as the ligand for the LDL receptor, mediating their hepatic uptake. - While chylomicrons have **Apo-B48**, which is a truncated form of Apo-B100, Apo-B100 itself is not found on chylomicron remnants.

Q: What is the primary product of fatty acid oxidation (β-oxidation)?

Acetyl CoA. ***Acetyl CoA*** - Beta-oxidation of fatty acids involves a series of reactions that cleave two-carbon units from the fatty acyl chain, forming **acetyl CoA**. - **Acetyl CoA** is the direct product of each cycle of β-oxidation and then enters the **citric acid cycle** to generate ATP or serves as a precursor for other anabolic pathways. *Malonyl CoA* - **Malonyl CoA** is a key intermediate in **fatty acid synthesis**, not degradation. - It's formed from acetyl CoA by acetyl-CoA carboxylase and acts as a substrate for **fatty acid synthase**, and also as a physiological inhibitor of carnitine palmitoyltransferase I (CPT-I), thereby regulating β-oxidation. *Ketone bodies* - **Ketone bodies** (**acetoacetate** and **β-hydroxybutyrate**) are produced from acetyl CoA in the liver during conditions of low glucose availability or prolonged fasting. - They serve as an alternative fuel source for tissues like the brain and muscles, but are secondary products derived from the condensation of acetyl CoA molecules, not the primary direct product of fatty acid breakdown itself. *Cholesterol* - **Cholesterol** is a steroid lipid synthesized from **acetyl CoA** through a complex multi-step pathway (via HMG-CoA reductase pathway). - It is an important structural component of cell membranes and a precursor for steroid hormones and bile acids, but not a direct product of fatty acid catabolism.

Q: Which of the following is a type of 17 OH steroid?

Cortisol. ***Cortisol*** - Cortisol is a **glucocorticoid** and is characterized by a **hydroxyl group (-OH)** at the 17th carbon position of its steroid nucleus. - This 17-OH group is crucial for its classification and biological activity as a **17-hydroxycorticosteroid** (17-OH steroid). *Testosterone* - Testosterone is an **androgen** and while it does have a hydroxyl group at the 17β position (making it a 17β-hydroxysteroid), it is NOT classified as a **17-OH steroid (17-hydroxycorticosteroid)**. - The term **"17-OH steroid"** specifically refers to **corticosteroids** with both a hydroxyl at C-17 and a dihydroxyacetone side chain, which testosterone lacks. - Testosterone has a simple hydroxyl at C-17β and lacks the characteristic corticosteroid side chain structure. *Progesterone* - Progesterone is a **progestogen** and lacks a hydroxyl group at the 17th carbon position. - It plays a role in the **menstrual cycle** and **pregnancy** and is primarily characterized by a keto group at C-3 and a two-carbon side chain with a carbonyl group at C-20. *None of the options* - This option is incorrect because **cortisol** is indeed a type of 17-OH steroid (17-hydroxycorticosteroid). - The presence of the 17-hydroxyl group along with the corticosteroid side chain is a defining characteristic of this classification.

Q: In a person fasting overnight with carnitine deficiency, which of the following chemicals increase in quantity in blood?

Fatty acid levels. ***Fatty acid levels*** - **Carnitine deficiency** impairs the transport of **long-chain fatty acids** into the mitochondria for beta-oxidation. - This leads to an accumulation of **fatty acids** in the blood as they cannot be efficiently metabolized for energy during fasting. - Therefore, **fatty acid levels increase** in the blood. *Ketone body levels* - **Ketone bodies** are produced from the **beta-oxidation of fatty acids** in the liver. - With **carnitine deficiency**, fatty acid oxidation is impaired, thus **reducing** the production of ketone bodies, not increasing them. *Glucose levels* - During **fasting**, the body relies on **gluconeogenesis** and **glycogenolysis** to maintain glucose levels. - With carnitine deficiency primarily affecting fat metabolism and preventing fatty acid utilization, the body cannot spare glucose effectively. - This leads to **hypoglycemia** (decreased glucose), not increased glucose levels. *Amino acid levels* - **Amino acid metabolism** is largely independent of **carnitine**. - While amino acids can be used for gluconeogenesis during fasting, carnitine deficiency does not directly cause an increase in circulating amino acid levels.

Question 1

Which of the following is a true difference between gangliosides and cerebrosides?

Accepted Answer

Charge difference

Answer

Specific carbohydrate composition

Answer

Location in the nervous system

Answer

Presence of glucose

Question 2

Enzyme deficient in Type I Hyperlipidemia?

Accepted Answer

Lipoprotein lipase

Answer

HMG CoA reductase

Answer

Peroxidase

Answer

Cholesterol acyl transferase

Question 3

Which of the following is monoenoic acid ?

Accepted Answer

Oleic acid

Answer

Linoleic acid

Answer

Linolenic acid

Answer

Arachidonic acid

Question 4

Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Palmitate

Answer

Citrate

Question 5

Apo-E deficiency is seen in which of the following conditions?

Accepted Answer

Type III hyperlipoproteinemia

Answer

Type II hyperlipoproteinemia

Answer

Type I hyperlipoproteinemia

Answer

Type IV hyperlipoproteinemia

Question 6

At which positions does pancreatic lipase hydrolyze the ester linkages of triacylglycerides?

Accepted Answer

1 and 3

Answer

1 and 2

Answer

2 and 3

Answer

Only 3

Question 7

Chylomicron remnants are associated with ?

Accepted Answer

Apo-E

Answer

Apo-C

Answer

Apo-A

Answer

Apo-B100

Question 8

What is the primary product of fatty acid oxidation (β-oxidation)?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Ketone bodies

Answer

Cholesterol

Question 9

Which of the following is a type of 17 OH steroid?

Accepted Answer

Cortisol

Answer

Progesterone

Answer

None of the options

Answer

Testosterone

Question 10

In a person fasting overnight with carnitine deficiency, which of the following chemicals increase in quantity in blood?

Accepted Answer

Fatty acid levels

Answer

Ketone body levels

Answer

Glucose levels

Answer

Amino acid levels

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?